HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.

AbstractOBJECTIVE:
To investigate the effectiveness of seasonal malaria chemoprevention (SMC) and community case management with long-acting artemisinin-based combination therapies (ACTs) for the control of malaria in areas of extended seasonal malaria transmission.
METHOD:
Individually randomised, placebo-controlled trial in the Ashanti Region of Ghana. A total of 2400 children aged 3-59 months received either: (i) a short-acting ACT for case management of malaria (artemether-lumefantrine, AL) plus placebo SMC, or (ii) a long-acting ACT (dihydroartemisinin-piperaquine, DP) for case management plus placebo SMC or (iii) AL for case management plus active SMC with sulphadoxine-pyrimethamine and amodiaquine. SMC or placebo was delivered on five occasions during the rainy season. Malaria cases were managed by community health workers, who used rapid diagnostic tests to confirm infection prior to treatment.
RESULTS:
The incidence of malaria was lower in children given SMC during the rainy season. Compared to those given placebo SMC and AL for case management, the adjusted hazard ratio (aHR) was 0.62 (95% CI: 0.41, 0.93), P = 0.020 by intention to treat and 0.53 (95% CI: 0.29, 0.95), P = 0.033 among children given five SMC courses. There were no major differences between groups given different ACTs for case management (aHR DP vs. AL 1.18 (95% CI 0.83, 1.67), P = 0.356).
CONCLUSION:
SMC may have an important public health impact in areas with a longer transmission season, but further optimisation of SMC schedules is needed to maximise its impact in such settings.
AuthorsHarry Tagbor, Gifty Dufie Antwi, Princess Ruhama Acheampong, Constance Bart Plange, Daniel Chandramohan, Matthew Cairns
JournalTropical medicine & international health : TM & IH (Trop Med Int Health) Vol. 21 Issue 2 Pg. 224-35 (Feb 2016) ISSN: 1365-3156 [Electronic] England
PMID26578353 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
Chemical References
  • Antimalarials
  • Artemisinins
  • Drug Combinations
  • Ethanolamines
  • Fluorenes
  • Quinolines
  • Amodiaquine
  • fanasil, pyrimethamine drug combination
  • artenimol
  • Sulfadoxine
  • artemisinin
  • piperaquine
  • Artemether
  • Lumefantrine
  • Pyrimethamine
Topics
  • Amodiaquine (therapeutic use)
  • Antimalarials (therapeutic use)
  • Artemether
  • Artemisinins (therapeutic use)
  • Chemoprevention (methods)
  • Child, Preschool
  • Drug Combinations
  • Drug Therapy, Combination
  • Ethanolamines (therapeutic use)
  • Female
  • Fluorenes (therapeutic use)
  • Ghana
  • Humans
  • Infant
  • Infant, Newborn
  • Lumefantrine
  • Malaria (prevention & control, transmission)
  • Male
  • Pyrimethamine (therapeutic use)
  • Quinolines (therapeutic use)
  • Rain
  • Seasons
  • Sulfadoxine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: